31.2 F
New York
Thursday, January 28, 2021

Eastgate Biotech Corp (OTCMKTS:ETBI) Bounces on Canadian Listing Potential

Must read

Artificial Intelligence Technology Solutions (OTCMKTS:AITX) Posts Major Gains on Breakout

The artificial intelligence industry has grown at a remarkable rate over the past half a decade or so and it is expected...

American Battery Metals Corp (OTCMKTS:ABML) Hitting Key Milestones

Over the course of the past week, American Battery Metals Corp (OTCMKTS:ABML) has been in focus among investors after the company announced...

American Green Inc (OTCMKTS:ERBB) Stock Gains Momentum on Amazon News

One of the more interesting operators in the cannabis space in 2020 is American Green Inc (OTCMKTS:ERBB), and this week, the company...

DSG Global Inc (OTCMKTS:DSGT) Hits Multi-Month High On Sudden Optimism

DSG Global Inc (OTCMKTS:DSGT) has been in the news over the past week or so after the company placed large orders through...

Eastgate Biotech Corp (OTCMKTS:ETBI) is a micro-cap name that has grabbed hold of the attention of traders during the stock’s recent bounce. The decline in shares had been monumental in April, but the stock managed to catch a bounce off penny support. The proximal catalyst for the bounce was the company’s announcement that it has entered into various agreements with Gunpowder Capital Corp., (CSE:GPC).

According to the release, the primary point of the relationship is to receive consultant services from GPC in a financial and regulatory advisor capacity in the going public process for listing on a Canadian stock exchange. We’ve witnessed 17% tacked on to share pricing for the stock in the past week, but this action is running counter to the larger trend in the name. However, ETBI has evidenced sudden upward volatility on many prior occasions. Moreover, the company has registered increased average transaction volume recently, with the past month seeing just shy of 1200% over what the stock has registered over the longer term.

Eastgate Biotech Corp (OTCMKTS:ETBI) bills itself as a company that produces and distributes innovative and healthy nutraceuticals that are based on natural therapies and absorbed naturally by the body.

The company notes that it utilizes state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that “all-too-often create dangerous side-effects and unexpected consequences for those trying to attain and maintain healthy lives.”

According to company materials, “Our research and development scientists have more than 60 years of combined experience and are dedicated to providing the best nutraceutical products for your natural comfort, health, and well-being.”

Find out when $ETBI stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

As noted above, ETBI is exploring the process of listing its shares in Canada. As noted in the recent release, as compensation to GPC, it looks like ETBI is prepared to fork over 15 thousand in Canadian dollars (or about $10,900 in USD). And once the company has listed in Canada, it appears as though there is a follow-on agreement whereby ETBI will continue to retain GPC in its advisory capacity for another five grand in Canadian dollars (or about $3,642 in USD) per month, along with an issuance of 8% of the company in common shares.”

And once the company has listed in Canada, the deal gets a bit steeper, as it appears there is a follow-on agreement whereby ETBI will continue to retain GPC in its advisory capacity for another five grand in Canadian dollars (or about $3,642 in USD) per month, along with an issuance of 8% of the company in common shares.”

“GPC has also agreed to lend Eastgate Seventy-Eight Thousand Dollars (“$78,000.00”) USD at a rate of fourteen percent (14%) per annum. The loan is secured by a personal guarantee by an officer of Eastgate and is convertible at any time before maturity into common shares of Eastgate at a price of $0.05 per share. Eastgate will also issue One Million (“1,000,000”) common stock purchase warrants to GPC. The warrants shall have a life of three years, and allow for the purchase of 1,000,000 Eastgate common shares at a price of $0.05 per share.”

Prior to this step, as we have covered previously, the company’s principal catalyst was its announcement of a Purchase and Sale Agreement to acquire OMNI Surgery and Anti-Aging Centre. According to the company’s mid-March press release on the acquisition, this investment will complement EastGate’s product development initiatives, potential clinical development, bolster revenues positively and increase the company’s asset base. “The private fully-accredited multi-specialty facility will serve as a vehicle for merger and acquisition activities of new product lines and medical groups and other existing health care clinics to optimize surgical procedures to improve treatment outcomes for patients.”

From what we can glean in the action, investors dramatically lost confidence in the stock in April. We aren’t exactly sure why. However, we will point out that one look at the company’s filings shows a rush to get current. That’s interesting.

Frankly, we’ve never seen a bad thing come of a sudden rush to get current with past quarterly filings. It’s possible that the granularity of detail by showing much more information chased a key investor out of the stock. But the reason for the move to file past quarterly reports (the company filed all of 2016 in quarterly reports over a three week period into mid-March) could have future advantages, such as further M&A activity or an up-listing option.

Currently trading at a market capitalization of $5.6M, ETBI has virtually no reported cash on the books, which stands against about $1.5M in total current liabilities. One should also note that debt has been growing over recent quarters. ETBI is pulling in trailing 12-month revenues of $94K. However, the company is seeing declines on the top line on a quarterly y/y basis, with revenues falling at a dramatic rate. We will update the story again soon as further details emerge. For continuing coverage on shares of $ETBI stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!

Latest article

Bombardier, Inc. (OTCMKTS:BDRBF) Uptrend at Risk: In Focus

British company Bombardier, Inc. (OTCMKTS:BDRBF) came into sharp focus among investors last week after a significant development. Major Triggers

American Battery Metals Corp (OTCMKTS:ABML) Points up on Surge of Momentum

One of the stocks to have seen a lot of action last week was that of American Battery Metals Corp (OTCMKTS:ABML) and...

Grayscale Ethereum Trust (ETH) (OTCMKTS:ETHE) Attempts To Rebound On Bullish Note

While the remarkable rally in Bitcoin has led to breathless speculation about its long term price, the recent rally in Grayscale Ethereum...

Sunhydrogen Inc (OTCMKTS:HYSR) Continues to Trend Higher on High Demand

One of the sectors to have come into significant focus among investors in recent times is the hydrogen...

Artificial Intelligence Technology Solutions (OTCMKTS: AITX) Moves Up Quickly On Solid Volume

The artificial intelligence industry has grown at a remarkable pace over the past half a decade or so and over the coming...